RECCE PHARMACEUTICALS LTD — Major Shareholding Notification 2017

Mar 14, 2017

Form 605

Corporations Act 2001 Section 671B

Notice of ceasing to be a substantial holder

To Company Name/Scheme	RECCE LIMITED
ACN/ARSN	73 124 849 065
1. Details of substantial holder(1)
Name	James Hamilton Bray Graham
ACN/ARSN (if applicable)
The holder ceased to be asubstantial holder on	9/3/2017
The previous notice was given to the company on	17/2/2016
The previous notice was dated	17/2/2016

2. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date ofchange	Person whoserelevant interestchanged	Nature ofChange (4)	ConsiderationGiven in relationto change(5)	Class (6) andnumber ofsecuritiesaffected	Person's votesaffected
9/3/2017	James Hamilton Bray Graham	Dilution in voting power as a result ofconversion of Class A PerformanceShares and sale of shares on market	$19,956	3.649.851	3.649.851

3. Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7), with the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable)	associationNature
N/A	N/A

4. Addresses

The addresses of persons named in this form are as follows:

and the property company of the company ofName
Mr James Hamilton Bray Graham
and the company of the company of	and the property of the con-

Signature

James Graham print name

capacity Director

date 15 / 3/2017

sign here